4D Pharma PLC
LSE:DDDD
Income Statement
Earnings Waterfall
4D Pharma PLC
Revenue
|
522k
GBP
|
Operating Expenses
|
-27.1m
GBP
|
Operating Income
|
-26.5m
GBP
|
Other Expenses
|
-27.4m
GBP
|
Net Income
|
-54m
GBP
|
Income Statement
4D Pharma PLC
Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+130%
|
1
+10%
|
0
-8%
|
1
+7%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(11)
|
(12)
|
(13)
|
(20)
|
(20)
|
(21)
|
(29)
|
(28)
|
(31)
|
(35)
|
(31)
|
(27)
|
(27)
|
|
Selling, General & Administrative |
(4)
|
(8)
|
(7)
|
(2)
|
(9)
|
(4)
|
(9)
|
(5)
|
(9)
|
(6)
|
(13)
|
(8)
|
(12)
|
|
Research & Development |
(7)
|
(4)
|
(6)
|
(14)
|
(11)
|
(20)
|
(19)
|
(24)
|
(20)
|
(28)
|
(16)
|
(19)
|
(15)
|
|
Depreciation & Amortization |
(0)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
(3)
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(11)
N/A
|
(12)
-12%
|
(13)
-10%
|
(20)
-53%
|
(20)
-1%
|
(21)
-5%
|
(29)
-36%
|
(28)
+2%
|
(31)
-8%
|
(34)
-11%
|
(31)
+10%
|
(27)
+12%
|
(27)
+2%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
1
|
1
|
1
|
1
|
0
|
1
|
1
|
(1)
|
(1)
|
0
|
0
|
(0)
|
0
|
|
Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
(4)
|
(3)
|
(0)
|
0
|
3
|
3
|
0
|
(44)
|
(44)
|
|
Total Other Income |
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
7
|
13
|
|
Pre-Tax Income |
(10)
N/A
|
(11)
-12%
|
(12)
-4%
|
(19)
-64%
|
(24)
-25%
|
(24)
-1%
|
(28)
-18%
|
(29)
-3%
|
(29)
0%
|
(31)
-5%
|
(30)
+2%
|
(65)
-113%
|
(57)
+11%
|
|
Net Income | ||||||||||||||
Tax Provision |
2
|
3
|
2
|
2
|
4
|
5
|
5
|
4
|
5
|
5
|
4
|
4
|
4
|
|
Income from Continuing Operations |
(8)
|
(8)
|
(10)
|
(17)
|
(20)
|
(19)
|
(24)
|
(25)
|
(24)
|
(26)
|
(26)
|
(61)
|
(54)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(8)
N/A
|
(8)
-7%
|
(10)
-23%
|
(17)
-73%
|
(20)
-20%
|
(19)
+6%
|
(24)
-23%
|
(25)
-6%
|
(24)
+4%
|
(26)
-7%
|
(26)
-1%
|
(61)
-134%
|
(54)
+11%
|
|
EPS (Diluted) |
-0.13
N/A
|
-0.13
N/A
|
-0.15
-15%
|
-0.26
-73%
|
-0.31
-19%
|
-0.29
+6%
|
-0.36
-24%
|
-0.38
-6%
|
-0.37
+3%
|
-0.26
+30%
|
-0.23
+12%
|
-0.4
-74%
|
-0.32
+20%
|